These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34684061)

  • 1. Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)-A 6-Month Pilot Study of a Single Woman's Experience Changes.
    Shirin S; Murray F; Goshtasebi A; Kalidasan D; Prior JC
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684061
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.
    Piltonen TT; Chen JC; Khatun M; Kangasniemi M; Liakka A; Spitzer T; Tran N; Huddleston H; Irwin JC; Giudice LC
    Hum Reprod; 2015 May; 30(5):1203-15. PubMed ID: 25750105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial.
    Kort DH; Lobo RA
    Am J Obstet Gynecol; 2014 Nov; 211(5):487.e1-6. PubMed ID: 24813595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden.
    Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE
    Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronized estradiol and progesterone therapy in primary, preinvasive endometrial cancer (1A/G1) in young women with polycystic ovarian syndrome.
    Stanosz S; von Mach-Szczypiński J; Sieja K; Koœciuszkiewicz J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2472-6. PubMed ID: 25157541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial.
    Behboudi-Gandevani S; Abtahi H; Saadat N; Tohidi M; Ramezani Tehrani F
    J Ovarian Res; 2019 Aug; 12(1):78. PubMed ID: 31470879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.
    Cinar N; Harmanci A; Demir B; Yildiz BO
    Hum Reprod; 2012 Jun; 27(6):1840-5. PubMed ID: 22473394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A; Yavuz T; Yucel O; Ozdemir I
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.